IV Drips for Skin: Doctors Warn of Dangerous Scam

Two medical professionals have issued a public health warning regarding the increasing popularity of intravenous skin-lightening treatments. They emphasize that cosmetology is not a recognized medical field in India, and individuals claiming this title often lack formal medical qualifications, likening them to wellness coaches. These aesthetic treatments are marketed as a 'scam alert' due to a lack of credible scientific evidence.

The perceived skin-lightening effects from IV glutathione are temporary and require ongoing, expensive treatments. The scientific basis for these claims is exceptionally poor, relying heavily on anecdotal reports rather than robust studies. Any positive outcomes are fleeting, as natural pigmentation returns once the high doses are stopped, leading to financial loss for consumers.

Beyond the financial strain, these treatments carry significant health risks. Because IV glutathione is not approved for cosmetic use, clinics often use custom-mixed solutions sourced from compounding pharmacies, bypassing standard regulations. This practice introduces severe risks, as evidenced by a US FDA safety alert in August 2026. This warning detailed potentially fatal infection-like symptoms in dozens of patients who received contaminated IV drips made with unregulated supplement-grade powder.

High-dose administration of IV glutathione has been linked to severe adverse reactions, including anaphylaxis, acute liver and kidney dysfunction, and life-threatening skin reactions like Stevens-Johnson syndrome and toxic epidermal necrolysis. Doctors stress that patient safety is frequently disregarded in favor of commercial interests, with these procedures being a lucrative trend operating outside evidence-based medicine.